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Abstract
Background Reconstruction of nasal lesions is complex due to the topography, mobile free margins and borders of anatomical
subunits. Reconstructive challenges can lead tomultiple revisional surgeries to achieve the final aesthetic result. This study aimed
to evaluate risk factors and predictors of revisional surgery in patients undergoing reconstruction after Mohs micrographic
surgery for nasal tumours.
Methods This was a prospective cohort study from April 2, 2008 to February 26, 2019. The study population included all
consecutive patients who underwentMohsmicrographic surgery for nasal skin cancer. Resection and reconstruction of nasal skin
cancer was performed by the Mohs team.
Results A total of 988 cases met our study inclusion criteria with 64 (6.5%) cases requiring unplanned surgical revision. Revision
rates were highest in the ala (9.0%, p < 0.05) and complex anatomical subunits (16.7%, p < 0.0001). In contrast, revision rates for
dorsum lesions were lowest (1.8%, p < 0.001). In terms of reconstructive modalities, local flaps resulted in significantly higher
rates of revision when compared to grafts (relative risk, 2.37; 95% CI, 1.15–5.0; p < 0.01). In terms of histological diagnosis,
squamous cell carcinoma had significantly higher revision rates when compared to basal cell carcinoma (p < 0.05).
Conclusions To our knowledge, this is the first study to report the risk factors and predictors of revision surgery in patients
undergoing MMS for nasal tumours. This study highlights that the reconstructive modality utilised affects the functional and
cosmetic outcome of MMS. We note that ala complex subunit lesions, squamous cell carcinoma and flap reconstruction were
associated with an increased risk of revision after Mohs reconstruction of nasal lesions.
Level of evidence: Level III, risk/prognostic; therapeutic study.
Trial registration number (Ref: PLA-19-20_A03) 04/02/2020.
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Introduction
Mohs’ micrographic surgery (MMS) has been increasingly
used in head and neck cutaneous oncology to minimise the
excisional defect by providing the most accurate method of
intraoperative histological assessment of tumour margins [1].
The British Association of Dermatologists recommend the use
of MMS primarily for complex skin cancers where confirma-
tion of complete clearance is paramount prior to reconstruc-
tion; complex cancers includes those of high-risk anatomical
site, such as the nose [2]. MMS leads to significantly fewer
recurrences when compared to simple surgical excision as
specimens are flattened and sliced horizontally, offering ex-
amination of up to 100% of resection margins [3–5].
Micrographic excision of nasal lesions typically produces de-
fects that require surgical reconstruction [6].
* Tom W. Andrew
Tom.Andrew@ncl.ac.uk
1 Department of Plastic and Reconstructive Surgery, Norfolk and
Norwich University Hospital NHS Foundation Trust, Norwich NR4
7UY, UK
2 Department of Dermatology, Norfolk and Norwich University
Hospital NHS Foundation Trust, Norwich NR4 7UY, UK
3 Norwich Medical School, University of East Anglia, Norwich, UK
4 Translational and Clinical Research Institute, Newcastle University,
Newcastle NE2 4HH, UK
European Journal of Plastic Surgery
https://doi.org/10.1007/s00238-020-01755-4
The nose is in the centre of the face and is highly hetero-
geneous in colour, texture and topography [7, 8]. To achieve
optimal aesthetic and functional outcomes, the surgeon must
consider a range of reconstructive options, depending on the
dimensions of the excisional defect, the structure of the
resected tissues and the involved aesthetic nasal subunit [9].
According to Burget and Menick [9], optimum aesthetic re-
sults require excision of the entire involved subunit. This has
been challenged by Rohrich and colleagues [10], suggesting
to minimise resection of healthy tissues with reconstruction of
the defect and not the entire subunit. They recommend com-
plementary procedures to enhance aesthetic outcome.
Improvements in analysis and planning combined with higher
standards for aesthetic results have resulted in the trend toward
an increased number of procedures [11]. In addition, multiple
staged procedures are often used to complete the sequence and
achieve the final aesthetic result [9, 10, 12, 13].
The aim of this project was to guide dermatological and
reconstructive surgeons and improve patient outcomes by
analysis of data from our prospectively collected cohort of
patients undergoing MMS to their nasal tumours in order to
advance the understanding, management and improve the out-
comes of patient care by identifying risk factors and predictors
for revision surgery. We also aimed to provide data that may
guide the reconstructive surgeon about service planning for
patients undergoing Mohs resection for skin cancer.
Patients and methods
This study was approved by the Clinical Audit and
Improvement Department at the Norfolk and Norwich
University Hospital (Ref: PLA-19-20_A03). The study popu-
lation included all consecutive patients who underwent Mohs
micrographic surgery for nasal skin cancer between April 2,
2008 and February 26, 2019. Resection and reconstruction of
nasal skin cancer were performed by the Mohs team (either a
dermatologist or plastic surgeon) at the Norfolk and Norwich
University Hospital Skin Tumour Unit. Treatment and out-
comes of nasal reconstruction following Mohs surgery were
obtained. The patient demographics and intraoperative data
were obtained from the electronic patient notes and electronic
theatre records. Histological data were acquired from the elec-
tronic patient notes. Follow-up data were entered from the
electronic patient notes. Nasal skin cancer lesions were de-
fined by anatomical subunit: medial canthus (n = 119), ala
(n = 312), columella (n = 5), dorsum (n = 243), complex (tu-
mour involved more than one nasal subunit at the time of
diagnosis) (n = 90) and tip (n = 219). One patient was exclud-
ed due to incomplete documentation.
We conducted analyses for gender, age, anatomical loca-
tion, histological diagnosis, reconstructive modalities and sur-
gical revision. All analyses were performed using Excel 15.0
(Microsoft Corporation, Redmond, WA) and GraphPad Prism
version 8.0.0 (GraphPad Software, Inc., San Diego, CA). Chi-
squared and Fisher’s exact test were used to identify statisti-
cally significant associated risk factors for surgical revision.
Fisher’s exact test was used for replicates of ≤ 5; otherwise,
chi-squared was used. In addition, unpaired T test and relative
risk ratio were used to analyse age and sex respectively.
Results
A total of 988 cases met our inclusion criteria for the study.
Table 1 describes the patient demographic data. The group
had a mean age of 67 (SD, 12 years; range, 18 to 89 years)
at the time of removal of nasal skin malignancy. The cohort
consisted of 426 (43.1%) males and 562 (56.9%) females.
The distribution of nasal tumours according to anatomical
subunit is outlined in Table 1. The most frequent location was
the nasal ala (32%), followed by the dorsum (25%), tip (22%),
medial canthus (12%) and columella (1%). In 90 cases (9%),
the tumour involvedmore than one nasal subunit at the time of
diagnosis (nasal complex). Basal cell carcinoma represented
930 (94%) of the cutaneous lesions compared to 38 (4%) cases
of squamous cell carcinoma (Table 2). The prevalence of basal
cell carcinoma is significantly greater in the ala region when
compared to other subunits (p < 0.05). In contrast, squamous
cell carcinoma is significantly more prevalent in nasal com-
plex tumours when compared to tumours contained to a single
subunit (p < 0.0001).
As shown in Table 3, results show that the most commonly
utilised reconstructive modality was a local flap (540 pa-
tients), followed by skin graft (277 patients), primary closure
Table 1 Patient and
defect characteristics Characteristic Finding
Patient characteristics
Age, years
Mean (SD) 67 (12)
Median (range) 69 (18–89)
Sex
Male 426 (43.12%)
Female 527 (56.895%)
Defect characteristics (n = 988)
Location-nose
Medial canthus 119 (12.04%)
Ala 312 (31.58%)
Collumella 5 (0.51%)
Dorsum 243 (24.60%)
Complex 90 (9.11%)
Tip 219 (22.17%)
SD, standard deviation
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(69 patients), secondary intention (39 patients), flap and car-
tilage graft (16 patients), flap and graft (13 patients), free tis-
sue transfer (6 patients) and prosthesis (1 patient). Local flaps
were the most frequently used reconstructive modality for all
subunits, except for the columella, which were most often
reconstructed with skin grafting. Cutaneous lesions of the na-
sal dorsum were more frequently closed primarily when com-
pared to other subunits (p < 0.0001).
There were 64 (6.5%) cases requiring unplanned surgical
revision (Table 4). Revision rates according to anatomical
subunit were medial canthus, 8 (6.7%); ala, 28 (9.0%,
p < 0.05); columella, 0 (0%); dorsum, 4 (1.8%, p < 0.001);
complex, 15 (16.7%, p < 0.0001) and tip, 9 (4.11%)
(Table 4). Revisions were also stratified by reconstructive mo-
dality. Local flaps resulted in significantly higher rate of revi-
sion when compared to grafts (relative risk, 2.37; 95% CI,
1.15–5.0; p < 0.01) (Table 4). This was also true when com-
paring all anatomical subunits collectively, as well as isolated
ala lesions (p < 0.05). Squamous cell carcinoma was associat-
ed with significantly higher revision rates when compared to
basal cell carcinoma (p < 0.05). There was no statistical dif-
ference between sex (relative risk 1.093; 95% CI, 0.682–1.75;
p = 0.357) and age (p = 0.6551) between patients who did and
did not require unplanned surgical revision.
Discussion
In this prospective cohort of patients requiring nasal reconstruc-
tion after MMS tumour resection, we investigated the variables
associated with unplanned surgical revision and determined
which characteristics were associated with higher revision rates.
Surgical revision was defined as those cases which required un-
planned operative revision. We observed a revision rate of 6.5%,
which varied from 0 to 16.7% according to the anatomical loca-
tion of the tumour. This was comparable to the literature involv-
ing complications of facial lesions, 6.69% [14]. In this study
population, the incidence of surgical complication is higher in
nasal lesions [14, 15]. Themean age of patients requiring surgical
revision was 66 years, compared to 67 years in the groupwithout
revision. We also identified that gender had no influence on
revision rates with 45% of revision cases being male, compared
to 43% in non-revision cases.
Tumour dimensions in the lower third of the nose are not
representative where lesions can cover multiple subsections of
anatomical subunits [9]. Anatomical subunits are a more sophis-
ticated measure of tumour burden when compared to tumour
dimensions [10]. We have therefore defined tumour burden by
anatomical subunit. This cohort, to our knowledge, is the first of
sufficient size to document an association between anatomical
subunit location and surgical revision. Most cancers involved the
ala, dorsum and nasal tip, as observed by Rohrich et al. [10]. We
Table 3 Reconstructive modality
and tumour location Reconstructive modality
(n = 988)
Medial
canthus
Ala Columella Dorsum Complex Tip Total
Local flap 37 234* 1 110 31* 127* 540*
Graft 50* 48 2 85 27 65 277
Direct closure 13 4 1 36**** 9 6 69
Secondary Intention 13 8 0 5 7 6 39
Free-flap 0 0 1 1 6 1 9
Flap and graft 3 6 0 0 2 2 13
Flap and cartilage 0 9 0 3 1 3 16
Prosthesis 0 0 0 0 1 0 1
Incomplete documentation 119 312 5 243 90 219 988
* = p < 0.05
**** = p < 0.0001
Table 2 Histology and location
Histology and location No. (%)
Histology (n = 988)
Basal cell carcinoma 930 (94.13%)
Squamous cell carcinoma 38 (3.85%)
Other 19 (1.92%)
Unknown 1 (0.10%)
Location (n = 988) BCC SCC p value
Medial canthus 110 6 0.2306
Ala 303 7 0.0333*
Columella 4 1 0.0318* (FE)
Dorsum 231 6 0.1818
Complex 73 11 < 0.0001****
Tip 209 38 0.2783
BCC, basal cell carcinoma; FE, Fisher exact test; SCC, squamous cell
carcinoma
* = p < 0.05
**** = p < 0.0001
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observed a significantly increased revision rates in the alar sub-
unit. We propose that this is due to the clinical challenges of alar
subunit reconstruction. The alar cartilages provide the support of
the lower third of the nose [7]. Zitelli [16] reported retraction and
protraction of the alar margin in alar subunit reconstruction,
which can be minimised with an appropriately designed bilobed
flap. Alternatively, the dorsal nasal flap [17], reportedly creates
less deformity at the dorsum and nasal tip when compared to the
bilobed flap. Despite this, it can produce upward rotation of the
nasal tip and alar rim retraction [10]. Lateral alar defects can be
reconstructed using a nasolabial flap; however, subsequent revi-
sion is not uncommon due to nasofacial angle blunting at the
pedicle of the flap. In addition, we have identified that complex
nasal defects have an increased risk of surgical revision. We
define complex nasal defects as involving multiple nasal sub-
units; these are intrinsically larger in size and often require more
intricate reconstruction. Similarly, Patel et al. observed that com-
plex facial defects are significantly associatedwith post-operative
complications, including the need for revision [18].
In contrast to other anatomical subunits, we observed re-
duced revision rates in dorsal nasal lesions. In this group,
primary closure was utilised more frequently as a reconstruc-
tive modality. We hypothesise that as direct closure is often
limited to small defects but [7], in part, the relative laxity and
mobility of the skin in this area lend itself better to simple
closure procedures. The reduced incidence of revision in dor-
sal lesions is due either to smaller dimensions or due to an
inherent reduction in post-operative complications in nasal
lesions reconstructed with primary closure.
We observed that squamous cell carcinoma was associated
with higher rates of revision compared to basal cell carcinoma.
To our knowledge, this is the first study to identify squamous
Table 4 Revision rate-based po-
tential risk factors Revision rates (n = 988) No. (%)
Revision surgery 64 (6.48%)
No revision surgery 924 (93.52%)
Location (n = 988) Revision surgery No revision surgery p value
Medial canthus 8 111 0.4539
Ala 28 284 0.0152*
Columella 0 5 0.2776
Dorsum 4 239 0.0002***
Complex 15 75 < 0.0001****
Tip 9 210 0.0533
Histology (n = 988) Revision surgery No revision surgery p value
Basal cell carcinoma 57 873 0.0414*
Squamous cell carcinoma 5 33
Reconstructive modality Revision surgery No revision surgery p value
All 45 772
Flap 37 503 0.0094**
Graft 8 269
Medial canthus 6 81
Flap 4 33 0.1076
Graft 2 48
Ala 25 257
Flap 24 210 0.0348*
Graft 1 47
Dorsum 2 193
Flap 1 109 0.1838 (FE)
Graft 1 84
Complex 7 51
Flap 4 27 0.4172
Graf 3 24
Tip 4 188
Flap 4 123 0.0741
Graft 0 65
Sex Revision surgery No revision surgery p value
Male 29 397 0.3667
Female 35 527
Age, years Revision surgery No revision surgery p value
66.68 67.32 0.6551
FE, Fisher exact test.
* = p < 0.05
** = p < 0.01
*** = p < 0.001
**** = p < 0.0001
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cell carcinoma as predictor for revisional surgery in nasal can-
cers. Squamous cell carcinoma often extends through the skin
to the mucosa by deep invasion requiring a greater number of
layers for complete excision when compared to BCC lesions.
In addition, squamous cell carcinomas are often larger, there-
by involving multiple subunits when compared to basal cell
carcinomas. Nasal structural support as well as mucosal lining
have optimised to provide a successful outcome of composite
nasal reconstruction [19]. Squamous cell carcinoma often in-
volves multiple anatomical subunits when compared to basal
cell carcinoma, demonstrating more extensive disease pro-
gression. Basal cell carcinoma in contrast has demonstrated
low levels of recurrence over a 5-year period when MMS has
been utilised [14].
In this study, we demonstrate significant differences in revi-
sion rates according to the reconstructive modality utilised. We
observed significantly fewer revisions in graft reconstruction
compared to flap reconstruction. Skin grafting has been de-
scribed as a good reconstructive option for resections limited to
small amounts of subcutaneous tissue, particularly in elderly
patients [9]. In contrast, local flaps use adjacent tissues to provide
an advantageous colour and contour match [10, 20]. Flaps have
been shown to have improved aesthetic outcomes in nasal recon-
structionwhen compared to skin grafts, as a result, there has been
paradigm shift toward their use [10]. We found that local flaps
were associated with an increased risk of revision. Local flap
reconstruction is often restricted for larger defects which intrin-
sically have an increased proportion of preoperative bone or
cartilage exposure. Newlove and Cook [21] had similar findings
with respect to the complication rates of flaps, who concluded
that flap repair is associated with a higher rate of complications.
Pedicled forehead flaps are routinely used for excisional defects
larger than 1.5 cm in diameter [10], or those involving more than
one nasal subunit. Forehead flaps are often regarded as the best
donor for nasal defect resurfacing because of its superior colour
and texture match [19]. The donor scar produces substantial
dissatisfaction in some patients which may require additional
revisional surgery to achieve the desired aesthetic result [22].
From our series, flaps were almost 2.5 times more likely to
require revisional surgery than grafts. Alam at al. [23] reported
similar findings amongst grafts and flaps, whichwere risk factors
for bleeding, infection and wound-healing complications.
Interestingly, Patel et al. [18] recorded over half of complicated
facial interpolated flaps after Mohs micrographic surgery oc-
curred in the nasal and medial canthal region, resulting in nasal
vestibular stenosis, saddle nose deformity, septal perforation and
epiphora [9, 15, 19]. Unfortunately, formal documentation re-
garding the indications for revision in all cases is incomplete;
however, anecdotally, the most common indications for ala revi-
sion surgerywere a bulky flap causing either cosmetic deformity,
airway obstruction or alar notching. The latter is a particularly
challenging problem to treat, with multiple options available to
help the reconstructive surgeon resolve the issue [24–26].
When nasal cartilage has been resected but the nasal mu-
cosa is intact, cartilage grafts can be inset traditionally as a
planned two-stage procedure. We did not find that cartilage
grafting increased risk of unplanned revision surgery. This is
in contrast to studies by Miller et al. [6] and Patel et al. [18]
who reported an increased risk of complications in interpolat-
ed flaps with cartilage grafting. This may be the result of a
relative small size (n = 16) for patients who underwent flap
with cartilage reconstruction. In our series, we follow the ad-
vice of Menick [27] who suggests that a three-stage approach
is less prone to complications. Driscoll [22] described equally
good cosmetic and functional outcomes pedicled nasolabial or
forehead flaps for composite nasal defects. Alar defects which
are reconstructed using paramedian forehead flaps are gener-
ally twice the size of defects reconstructed with nasolabial
flaps. Analysis of nasolabial and forehead flaps demonstrated
that reconstructive outcomes were determined by the technical
aspects of flap execution in contrast to the choice of flap [27].
A prosthesis was employed as a reconstructive modality
only once in our cohort. Prosthesis maybe an appropriate re-
constructive modality in lesions requiring total or near total
amputation of the nose, especially in patients with significant
comorbidities.
We acknowledge the limitations of our study. Reconstructive
outcomes were measured in a single unit, potentially limiting
external validity and generalizability with regard to reconstruc-
tive techniques and documentation. We did not specifically ana-
lyse comorbidities, smoking status or the use of antiplatelets/
anticoagulants- unlike Miller et al. [6].
We have demonstrated that ala and complex subunit le-
sions, squamous cell carcinoma and flap reconstruction were
predictive indicators for revisional surgery in nasal reconstruc-
tion following MMS. Importantly, we showed that flap recon-
struction for ala lesions significantly increased the risk of sur-
gical revision. We have also demonstrated that lesions of the
dorsum have a significantly reduced risk of surgical revision
compared to other subunits, and interestingly, dorsum lesions
were reconstructed with primary closure more than any other
group. This study equips the resecting Mohs and/or recon-
structive surgeons with the knowledge required to facilitate
surgical planning, patient counselling and scheduling issues
in patients with nasal skin cancer lesions.
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